Key facts
- This page summarizes Joseph R. Young's Form 4 filing for Vera Therapeutics, Inc. (VERA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 16 Mar 2026, 18:52.
Joseph R. Young - 13 Mar 2026 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)
- Reporting relationship
- SVP, FINANCE, CHIEF ACCT OFFCR
- Issuer ticker
- VERA
- Reported as of
- 13 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 Mar 2026, 18:52:14 UTC
- Prior SEC filing
- 25 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joseph R. Young
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Joseph R. Young filed Form 4 for Vera Therapeutics, Inc. (VERA) on 16 Mar 2026.
Change
- Previous filing in this sequence was filed on 25 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001861684
Primary reporting owner
Young Joseph R
- Relationship
- SVP, FINANCE, CHIEF ACCT OFFCR
- Address
- C/O VERA THERAPEUTICS, INC., 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
- Signature
- /s/ Joseph R. Young
- Signature date
- 16 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VERA
transaction
Class A Common Stock
Options Exercise
- Transaction value
- Shares
- +10,000
- Change %
- +15%
- Price
- $3.94*
- Shares after
- 75,754
- Date
- 13 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VERA
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- Shares
- -10,000
- Change %
- -21%
- Price
- $0.000000*
- Shares after
- 38,589
- Date
- 13 Mar 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 10,000
- Exercise price
- $3.94
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Includes 1,032 shares acquired pursuant to the Company's 2021 Employee Stock Purchase Plan.
Footnote F2
1/4 of the shares subject to the option vested on March 9, 2022, and 1/48 of the shares vest monthly thereafter.